Drug Shortage Report for SODIUM CHLORIDE BACTERIOSTATIC INJ

Last updated on 2025-10-16 History
Report ID 255312
Drug Identification Number 00402249
Brand name SODIUM CHLORIDE BACTERIOSTATIC INJ
Common or Proper name SODIUM CHLORIDE BACTERIOSTATIC INJECTION 0.9%
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 30 mL vial / fiole
ATC code V07AB
ATC description ALL OTHER NON-THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-10-31
Actual start date
Estimated end date
Actual end date 2025-10-15
Shortage status Avoided shortage
Updated date 2025-10-16
Company comments Product on allocation.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2025-10-16 French Compare
v25 2025-10-16 English Compare
v24 2025-10-16 French Compare
v23 2025-10-16 English Compare
v22 2025-10-07 French Compare
v21 2025-10-07 English Compare
v20 2025-10-01 English Compare
v19 2025-09-03 French Compare
v18 2025-09-03 English Compare
v17 2025-09-01 English Compare
v16 2025-08-26 French Compare
v15 2025-08-26 English Compare
v14 2025-08-11 French Compare
v13 2025-08-11 English Compare
v12 2025-08-11 French Compare
v11 2025-08-11 English Compare
v10 2025-08-11 French Compare
v9 2025-08-11 English Compare
v8 2025-05-16 French Compare
v7 2025-05-16 English Compare

Showing 1 to 20 of 26